Prevention of Episodic Migraine with AMG 334, a Human Anti-Calcitonin Gene-Related Peptide Receptor Monoclonal Antibody: Phase 2 Study Results and 52-Week Analysis of Open-Label Extension (S26.002)
Neurology | December 7, 2023 | Volume: 86 | Issue: 16_supplement | Pages: No page available
Prevention of Episodic Migraine with AMG 334, a Human Anti-Calcitonin Gene-Related Peptide Receptor Monoclonal Antibody: Phase 2 Study Results and 52-Week Analysis of Open-Label Extension (I3.001)
Neurology | December 7, 2023 | Volume: 86 | Issue: 16_supplement | Pages: No page available